Teva Settles Claims Over Delayed Generic Asthma Inhalers

Teva Pharmaceuticals has settled a 2023 lawsuit by a coalition of union healthcare funds accusing the company of thwarting the introduction of a generic version of its QVAR inhalers to the...

Already a subscriber? Click here to view full article